Life Sciences Center (LSC) have discovered a unique way for cells to silence specific genes without cutting DNA. This ...
A live webcast of the fireside chat will be available on the "Events & Presentations" page in the Investors section of the Company's website at https://crisprtx.gcs-web.com/events. A replay of the ...
In a phase 2 trial, a gene therapy reduced angioedema attacks, which could significantly change the quality of life for ...
In recent years, scientists have created a range of new methods based on CRISPR-Cas technology for precisely editing the ...
Crispr has already secured a historic first approval for a CRISPR/Cas9 drug and has several more potential blockbuster ...
Jennifer Doudna, the co-developer of CRISPR, says there’s a “coming revolution” in climate-adapted crops and animals.
Genes contain instructions for making proteins, and a central dogma of biology is that this information flows from DNA to RNA ...
There is no shortage of surprises and twists in the decade-long fight over the control of dominant IP in the CRISPR space.
Salim Syed’s rating is based on a combination of encouraging developments surrounding Crispr Therapeutics AG. Firstly, the pricing of Casgevy in Saudi Arabia appears to be around $2 million per ...
CRISPR Therapeutics AG (NASDAQ:CRSP – Get Free Report) has been given an average recommendation of “Hold” by the nineteen brokerages that are covering the company, Marketbeat Ratings reports. Two ...